Cargando…

B Cell, Th17, and Neutrophil Related Cerebrospinal Fluid Cytokine/Chemokines Are Elevated in MOG Antibody Associated Demyelination

BACKGROUND: Myelin oligodendrocyte glycoprotein antibody (MOG Ab) associated demyelination represents a subgroup of autoimmune demyelination that is separate from multiple sclerosis and aquaporin 4 IgG-positive NMO, and can have a relapsing course. Unlike NMO and MS, there is a paucity of literature...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kothur, Kavitha, Wienholt, Louise, Tantsis, Esther M, Earl, John, Bandodkar, Sushil, Prelog, Kristina, Tea, Fiona, Ramanathan, Sudarshini, Brilot, Fabienne, Dale, Russell C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769285/ https://www.ncbi.nlm.nih.gov/pubmed/26919719 http://dx.doi.org/10.1371/journal.pone.0149411

Ejemplares similares

Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton
por: Dale, Russell C., et al.
Publicado: (2014)

Utility of CSF Cytokine/Chemokines as Markers of Active Intrathecal Inflammation: Comparison of Demyelinating, Anti-NMDAR and Enteroviral Encephalitis
por: Kothur, Kavitha, et al.
Publicado: (2016)

Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination
por: Ramanathan, Sudarshini, et al.
Publicado: (2018)

Failure of alemtuzumab therapy in three patients with MOG antibody associated disease
por: Seneviratne, Sinali O., et al.
Publicado: (2022)

Pathogenesis of autoimmune demyelination: from multiple sclerosis to neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody‐associated disease
por: Lopez, Joseph A, et al.
Publicado: (2021)

Effects of the Positive Threshold and Data Analysis on Human MOG Antibody Detection by Live Flow Cytometry
por: Tea, Fiona, et al.
Publicado: (2020)

Decreased cerebrospinal fluid kynurenic acid in epileptic spasms: A biomarker of response to corticosteroids
por: Yan, Jingya, et al.
Publicado: (2022)

International multicenter examination of MOG antibody assays
por: Reindl, Markus, et al.
Publicado: (2020)

Overlapping central and peripheral nervous system syndromes in MOG antibody–associated disorders
por: Rinaldi, Simon, et al.
Publicado: (2020)

Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination
por: Tea, Fiona, et al.
Publicado: (2019)

Humoral signatures of MOG-antibody-associated disease track with age and disease activity
por: Spatola, Marianna, et al.
Publicado: (2023)

Dopamine-2 receptor extracellular N-terminus regulates receptor surface availability and is the target of human pathogenic antibodies from children with movement and psychiatric disorders
por: Sinmaz, Nese, et al.
Publicado: (2016)

Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS
por: Kim, Sung-Min, et al.
Publicado: (2015)

Treatment Approaches for MOG-Ab-Associated Demyelination in Children
por: Hacohen, Yael, et al.
Publicado: (2019)

MOG antibodies in combined central and peripheral demyelination syndromes
por: Vazquez Do Campo, Rocio, et al.
Publicado: (2018)

Epitope specificity of demyelinating MOG-specific autoantibody responses
por: Brehm, U., et al.
Publicado: (1998)

Anti-MOG autoantibodies pathogenicity in children and macaques demyelinating diseases
por: Serguera, Che, et al.
Publicado: (2019)

Differential Binding of Autoantibodies to MOG Isoforms in Inflammatory Demyelinating Diseases
por: Schanda, Kathrin, et al.
Publicado: (2021)

Refractory MOG-Associated Demyelinating Disease in a Pediatric Patient
por: Kroenke, Eve, et al.
Publicado: (2022)

Tumefactive Demyelination—A Rare Presentation of Anti-MOG Syndrome
por: Sivadasan, Sesh, et al.
Publicado: (2022)

Temporal Dynamics of MOG Antibodies in Children With Acquired Demyelinating Syndrome
por: Wendel, Eva Maria, et al.
Publicado: (2022)

Cerebrospinal fluid metabolomics: detection of neuroinflammation in human central nervous system disease
por: Yan, Jingya, et al.
Publicado: (2021)

Case Report: Anti-NMDAR Encephalitis With Anti-MOG CNS Demyelination After Recurrent CNS Demyelination
por: Ren, Bing-Yan, et al.
Publicado: (2021)

Brain histopathological study and prognosis in MOG antibody‐associated demyelinating pseudotumor
por: Shu, Yaqing, et al.
Publicado: (2019)

COVID-19 vaccine associated demyelination & its association with MOG antibody
por: Netravathi, M., et al.
Publicado: (2022)

Distinct serum and cerebrospinal fluid cytokine and chemokine profiles in autoantibody-associated demyelinating diseases
por: Hofer, Livia S, et al.
Publicado: (2019)

Intractable Hiccup in Demyelinating Disease with Anti-Myelin Oligodendrocyte Glycoprotein (MOG) Antibody
por: Akaishi, Tetsuya, et al.
Publicado: (2016)

Influence of type I IFN signaling on anti-MOG antibody-mediated demyelination
por: Berg, Carsten Tue, et al.
Publicado: (2017)

Mapping autoantigen epitopes: molecular insights into autoantibody-associated disorders of the nervous system
por: Sinmaz, Nese, et al.
Publicado: (2016)

Expanding Role of T Cells in Human Autoimmune Diseases of the Central Nervous System
por: Pilli, Deepti, et al.
Publicado: (2017)

Frequency of MOG-IgG in cerebrospinal fluid versus serum
por: Pace, Samuel, et al.
Publicado: (2022)

Chemokines in Coronavirus-Induced Demyelination
por: Trifilo, Matthew J., et al.
Publicado: (2005)

Defining distinct features of anti-MOG antibody associated central nervous system demyelination
por: Weber, Martin S., et al.
Publicado: (2018)

The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults
por: de Mol, CL, et al.
Publicado: (2019)

Development of a translational inflammation panel for the quantification of cerebrospinal fluid Pterin, Tryptophan-Kynurenine and Nitric oxide pathway metabolites
por: Yan, Jingya, et al.
Publicado: (2022)

Pro‐inflammatory dopamine‐2 receptor‐specific T cells in paediatric movement and psychiatric disorders
por: Pilli, Deepti, et al.
Publicado: (2020)

A Fulminant Case of Demyelinating Encephalitis With Extensive Cortical Involvement Associated With Anti-MOG Antibodies
por: Hochmeister, Sonja, et al.
Publicado: (2020)

Swimming Exercise Ameliorates Symptoms of MOG-Induced Experimental Autoimmune Encephalomyelitis by Inhibiting Inflammation and Demyelination in Rats
por: Kim, Ji-Youn, et al.
Publicado: (2020)

Myelin Oligodendrocyte Glycoprotein (MOG)-IgG Associated Demyelinating Disease: Our Experience with this Distinct Syndrome
por: Pujari, Shripad S., et al.
Publicado: (2021)

Involvement of β-chemokines in the development of inflammatory demyelination
por: Banisor, Ileana, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_vobjcv0cdh5u0aaqsmqah03se9